Umbelliferone

Umbelliferone is a naturally occurring hydroxylated coumarin compound found in plants such as carrots, parsley, and coriander that exerts biological activity primarily through antioxidant mechanisms and modulation of apoptotic pathways. Research suggests it may inhibit cancer cell proliferation, demonstrate antimicrobial activity, and protect cellular DNA, though most evidence remains preclinical.

Origin & History

Umbelliferone (7-hydroxycoumarin) is a naturally occurring phenolic compound found in various plants including fennel, carrot, celery, noni fruit, and Hydrangea species. It appears as a white to gray-brown crystalline solid and is typically extracted using solvent methods like acetone from plant roots, rhizomes, or fruits.

Historical & Cultural Context

Umbelliferone-containing plants have been used for over 2000 years in Ayurveda and Unani medicine for digestion and inflammation, while Traditional Chinese Medicine employed Cnidium and Hydrangea for detoxification and women's health. The compound itself was first identified structurally in 1842, though isolated umbelliferone was not traditionally used.

Health Benefits

• May support DNA protection from cigarette-induced damage (preliminary evidence from noni juice trial containing umbelliferone, n=40)
• Potential antimicrobial activity against bacteria and fungi (in vitro evidence only)
• May inhibit cancer cell proliferation through apoptosis induction (in vitro studies on MCF-7 cells, IC50 50-100 μM)
• Possible antioxidant effects through DPPH radical scavenging (in vitro evidence)
• May support skin health through tyrosinase inhibition (in vitro IC50 ~20 μM, no human studies)

How It Works

Umbelliferone acts as a potent antioxidant by scavenging reactive oxygen species (ROS) through its hydroxyl group at the 7-position of the coumarin backbone, thereby reducing oxidative stress-induced DNA damage. It modulates apoptosis in cancer cells by upregulating pro-apoptotic proteins such as Bax and downregulating anti-apoptotic Bcl-2, triggering caspase-3 activation. Additionally, umbelliferone inhibits cyclooxygenase (COX) enzymes and suppresses NF-κB signaling, contributing to its proposed anti-inflammatory and antimicrobial effects.

Scientific Research

Clinical evidence for isolated umbelliferone is extremely limited. Only one Phase I pharmacokinetic study (n=12) tested 250 mg oral doses for sulfotransferase activity (PMID: 16424369). A small RCT on noni juice containing trace amounts of umbelliferone (n=40 smokers) showed reduced DNA adducts after 1 month (PMID: 16506860), but effects cannot be attributed to umbelliferone alone.

Clinical Summary

The most direct human evidence comes from a single randomized controlled trial (n=40) examining noni juice containing umbelliferone among cigarette smokers, which reported reduced urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, though umbelliferone was not isolated as the sole active compound. No clinical trials have evaluated isolated umbelliferone supplementation in humans, making it impossible to attribute specific dosage-response relationships. Antimicrobial activity against gram-positive bacteria (including Staphylococcus aureus) and Candida species has been demonstrated in multiple in vitro studies, with minimum inhibitory concentrations (MICs) in the range of 64–256 µg/mL. Anticancer effects, including apoptosis induction in hepatocellular and breast cancer cell lines, are documented exclusively in in vitro and rodent models, representing early-stage preclinical evidence only.

Nutritional Profile

Umbelliferone (7-hydroxycoumarin) is a pure phytochemical compound, not a whole food, and therefore contains no macronutrients (0g protein, 0g fat, 0g carbohydrates), no dietary fiber, vitamins, or minerals in isolated form. Molecular weight: 162.14 g/mol. Classified as a hydroxylated coumarin (benzopyrone derivative) and a member of the phenylpropanoid biosynthetic family. Naturally occurring in plants of the Apiaceae/Umbelliferae family including carrots, coriander, fennel, and parsley, typically at concentrations of 0.01–0.5 mg/g dry weight depending on plant source. Also found in noni juice (Morinda citrifolia) as a minor constituent. As a bioactive compound, its primary relevance is pharmacological rather than nutritional: it exhibits UV-absorbing properties (absorption maximum ~325 nm), acts as a fluorescent marker at physiological pH, and functions as a precursor to other hydroxycoumarins. Bioavailability data in humans is limited; in vitro and animal studies suggest moderate intestinal absorption due to its relatively small, lipophilic structure (LogP ~1.24), with hepatic glucuronidation and sulfation as primary Phase II metabolic pathways. In context of dietary sources (e.g., noni juice trial referenced), intake levels are far below pharmacologically active concentrations (IC50 50–100 μM) demonstrated in cell studies, meaning isolated compound concentrations studied in vitro are not achievable through normal dietary consumption.

Preparation & Dosage

No established therapeutic dosages due to lack of clinical trials. Pharmacokinetic study used 250 mg single oral dose. Commercial supplements contain 10-50 mg/day umbelliferone equivalents, but these are unstudied. In food sources: noni juice provides ~0.75-7.5 mg/day from 750 mL. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Scopoletin, herniarin, vitamin C, quercetin, resveratrol

Safety & Interactions

Umbelliferone has not been evaluated for safety in dedicated human clinical trials, so formal tolerability data are lacking. As a coumarin derivative, it may potentiate the anticoagulant effects of warfarin and other vitamin K antagonists by competing with coumarin metabolism via CYP2A6 and CYP1A2 hepatic enzymes, warranting caution in patients on blood thinners. High-dose coumarins have historically been associated with hepatotoxicity in animal studies, though umbelliferone specifically has not been linked to liver injury in available literature. Pregnant or breastfeeding individuals should avoid supplemental umbelliferone due to the complete absence of safety data in these populations.